Results 41 to 50 of about 7,515,540 (162)

Manipulation of Viral MicroRNAs as a Potential Antiviral Strategy for the Treatment of Cytomegalovirus Infection

Viruses, 2017
Cytomegalovirus (CMV) infection leads to notable morbidity and mortality in immunosuppressed patients. Current antiviral drugs are effective but seriously limited in their long-term use due to their relatively high toxicity.
Jiang Deng, Jun Xiao, Ping Ma, Bo Gao, Feng Gong, Liping Lv, Yanyu Zhang, Jinbo Xu   +7 more
doaj   +1 more source

Performance of Nurses in Neonatal Intensive Care Unit Regarding Transfusion of Blood and Blood Products [PDF]

Journal of Evidence-Based Care, 2020
Background: Critically ill neonates receiving blood products are at risk of transfusion-related complications. The quality of nursing care in this regard can be enhanced through continuous evaluations.
Samane Sefatbaqa, Seyedeh Roqayeh JafarianAmiri, Ali Zabihi, Parisa Pourdad, Afsaneh Arzani   +4 more
doaj   +1 more source

Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018

Transfusion, 2019
On November 29, 2018, experts in the field of infectious diseases, pathogen reduction technologies (PRTs) and other participants from blood centers, academia, and industry gathered at the Food and Drug Administration (FDA) White Oak Campus in Silver ...
C. Atreya, S. Glynn, M. Busch, S. Kleinman, E. Snyder, S. Rutter, J. AuBuchon, W. Flegel, David Reeve, D. Devine, C. Cohn, B. Custer, R. Goodrich, R. Benjamin, Anna Razatos, J. Cancelas, S. Wagner, M. Maclean, M. Gelderman, A. Cap, P. Ness   +20 more
semanticscholar   +1 more source

Immunogenicity and Toxicity of Different Adjuvants Can Be Characterized by Profiling Lung Biomarker Genes After Nasal Immunization

Frontiers in Immunology, 2020
The efficacy of vaccine adjuvants depends on their ability to appropriately enhance the immunogenicity of vaccine antigens, which is often insufficient in non-adjuvanted vaccines. Genomic analyses of immune responses elicited by vaccine adjuvants provide
Eita Sasaki, Hideki Asanuma, Haruka Momose, Keiko Furuhata, Takuo Mizukami, Isao Hamaguchi   +5 more
doaj   +1 more source

Transfusion-transmitted occult hepatitis B virus infection: current understanding, challenges, and its implication in blood safety

Frontiers in Immunology
Occult hepatitis B virus infection (OBI) represents a specific form of hepatitis B virus (HBV)infection characterized by the presence of replication-competent HBV DNA in the liver despite a negative blood test for hepatitis B surface antigen (HBsAg). Due
Linbin Huang, Baoren He, Qiuhong Mo, Bin Li, Xipeng Yan, Rongji Lai, Xinwei Wang, Jinlian Li, Mingshuang Lai, He Xie, Jujun Sun, X. Ye, Limin Chen   +12 more
semanticscholar   +1 more source

One Health approach for West Nile virus surveillance in the European Union: relevance of equine data for blood safety

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2019
West Nile virus (WNV) infection is notifiable in humans and equids in the European Union (EU). An area where a human case is detected is considered affected until the end of the mosquito transmission season (week 48) and blood safety measures have to be ...
Johanna J. Young, D. Coulombier, D. Domanović, H. Zeller, C. Gossner   +4 more
semanticscholar   +1 more source

Hepatitis E virus infection among blood donors in Zhengzhou

Zhongguo shuxue zazhi
[Objective] To analyze the infection status of hepatitis E virus (HEV) among blood donors in Zhengzhou, so as to provide data support for formulating local blood screening strategies.
ZHAO Hongna, WEI Yueguang, YAN Lumin, TU Tiantian, WANG Shumin, WEI Yihui, WANG Yifang, ZHAO Lei, CHEN Mingjun   +8 more
doaj   +1 more source

Blood under pressure: how climate change threatens blood safety and supply chains.

Lancet Planetary Health
Climate change substantially threatens public health, including the blood supply chain, which is crucial for medical treatments such as surgeries, trauma care, and chronic disease management.
Elvina Viennet, Melinda M Dean, Jorga Kircher, Karin Leder, Yuming Guo, P. Jones, Helen M. Faddy   +6 more
semanticscholar   +1 more source

Appropriateness and safety of blood transfusion [PDF]

BMJ, 2005
We are spending a lot on safety and little on effectiveness F or a decade, huge sums have been spent on reducing infectious risks of blood transfusion in the United Kingdom. Since it seems paradoxical to finesse the safety of a medication when it is often used unnecessarily, we need to invest in understanding when transfusion will be effective.1 ...
Brian, McClelland, Marcela, Contreras
openaire   +2 more sources

Application of hazard vulnerability analysis on risk assessment in a blood bank

Zhongguo shuxue zazhi
Objective To conduct hazard vulnerability analysis(HVA) in a blood bank, aimed to identify high-risk events and optimize emergency management measures.
ZHANG Yang, LIN Yongju, CHEN Jinyan, LUO Weifeng, YANG Wei, LIANG Huaqin   +5 more
doaj   +1 more source